Michael D. Goldberg

Michael has enabled pioneering companies that have advanced patient care in oncology, cardiology and immunology based on genomics and related areas of digital technology for more than three decades. He has experience as a company founder, CEO and Silicon Valley venture capitalist focused on biotechnology.

Michael has been an investor and board member of numerous venture-backed life science companies, including: Genomic Health, CareDx, Crescendo and iRhythm. He has also served on boards and advisory boards of a number of industry, academic and public policy institutions including: the California Institute of Regenerative Medicine, the Harvard Center for Genetics and Genomics, the Berkeley Center for Law and Technology, the Western Association of Venture Capitalists and the Stanford Distinguished Career Institute.

Michael is a graduate of Brandeis University (BA) and the Stanford Graduate School of Business (MBA).